Table 2

Baseline characteristics of the first 100 patients referred

CharacteristicPatients, n=100
Sex, n (%)
 Male
 Female
62 (62)
38 (38)
Age, years, mean (SD, range)62.9 (10.5, 39–83)
Source of referral, n (%)
 Cardiologist
 Lipidologist
 GP
 Stroke physician
68 (68)
29 (29)
2 (2)
1 (1)
Patients with CVD, n (%)80 (80)
 High risk*
 Very high risk*
 Patients without CVD, n (%)
42 (42)
35 (35)
20 (20)
FH, n (%)21 (21)
Lipid profile, mmol/L, mean (SD, range)
 Total cholesterol
 LDL-C
 TG
 HDL-C
6.6 (1.9, 2.2–12.2)
4.0 (1.8, 0.7–9.8)
2.9 (1.7, 0.4–7.4)
1.4 (0.4, 0.7–2.4)
Statin status, n (%)
 Intolerant/some intolerance
 Tolerant
 Unknown
56 (56)
41 (41)
3 (3)
Lipid-lowering treatment, n (%)
 Atorvastatin
 Rosuvastatin
 Ezetimibe
 Statin and ezetimibe
33 (33)
39 (39)
28 (28)
36 (36)
  • *Based on criteria from the NICE.13 14

  • CVD, cardiovascular disease; FH, familial hypercholesterolaemia; GP, general practitioner; HDL, high-density lipoprotein-cholesterol; LDL-C, low-density lipoprotein-cholesterol; NICE, National Institute for Health and Care Excellence; TG, triglycerides.